As public awareness rises, doctors are being called to bridge the knowledge gap, offer screening, and guide patients through complex and evolving risks.
With findings that human leukocyte antigen-II (HLA-II) heterozygosity is associated with reduced risk of developing lung cancer, with particular benefits to smokers, Mount Sinai researchers add evidence to the theory of the immune system's protective function against cancer.